Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration. - Wikidata - awgldk - TriplyDB

Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration.

Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration.

http://www.wikidata.org/entity/Q34989613

about

MDMA for the treatment of mood disorder: all talk no substance?3,4-Methylenedioxymethamphetamine's (MDMA's) Impact on Posttraumatic Stress Disorder Pharmacological enhancement of exposure-based treatment in PTSD: a qualitative review 3,4-methylenedioxymethamphetamine (MDMA): current perspectives The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study.Is ecstasy an "empathogen"? Effects of ±3,4-methylenedioxymethamphetamine on prosocial feelings and identification of emotional states in others From Autism to Eating Disorders and More: The Role of Oxytocin in Neuropsychiatric Disorders Legal highs: staying on top of the flood of novel psychoactive substances Empathic accuracy and oxytocin after tryptophan depletion in adults at risk for depression.Effects of MDMA Injections on the Behavior of Socially-Housed Long-Tailed Macaques (Macaca fascicularis)No evidence that MDMA-induced enhancement of emotional empathy is related to peripheral oxytocin levels or 5-HT1a receptor activation How MDMA's pharmacology and pharmacokinetics drive desired effects and harms.A window into the intoxicated mind? Speech as an index of psychoactive drug effects Acute prosocial effects of oxytocin and vasopressin when given alone or in combination with 3,4-methylenedioxymethamphetamine in rats: involvement of the V1A receptor MDMA and methamphetamine: some paradoxical negative and positive mood changes in an acute dose laboratory study.The behavioral, anatomical and pharmacological parallels between social attachment, love and addiction.Effects of MDMA and Intranasal oxytocin on social and emotional processing.Multifaceted empathy of healthy volunteers after single doses of MDMA: A pooled sample of placebo-controlled studies Plasma oxytocin concentrations following MDMA or intranasal oxytocin in humans 'Ecstasy' as a social drug: MDMA preferentially affects responses to emotional stimuli with social content.MDMA effects consistent across laboratories.A randomized, controlled pilot study of MDMA (± 3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD).MDMA enhances emotional empathy and prosocial behavior History and future of the Multidisciplinary Association for Psychedelic Studies (MAPS).The prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA): Controlled studies in humans and laboratory animals.The Psychopharmacology of ±3,4 Methylenedioxymethamphetamine and its Role in the Treatment of Posttraumatic Stress Disorder.Treating posttraumatic stress disorder with MDMA-assisted psychotherapy: A preliminary meta-analysis and comparison to prolonged exposure therapy.Clinical applications of hallucinogens: A review.Acute effects of MDMA (3,4-methylenedioxymethamphetamine) on EEG oscillations: alone and in combination with ethanol or THC (delta-9-tetrahydrocannabinol).Next-generation treatments for mental disorders.Acute Effects of the Novel Psychoactive Drug 2C-B on Emotions Effects of acute doses of prosocial drugs methamphetamine and alcohol on plasma oxytocin levels.The neuropharmacology of prolactin secretion elicited by 3,4-methylenedioxymethamphetamine ("ecstasy"): a concurrent microdialysis and plasma analysis study.Editorial: Oxytocin's routes in social behavior: into the 21st century Acute effects of MDMA on autonomic cardiac activity and their relation to subjective prosocial and stimulant effects.Helping oxytocin deliver: considerations in the development of oxytocin-based therapeutics for brain disorders.Targeting the Oxytocin System to Treat Addictive Disorders: Rationale and Progress to Date Oxytocin decreases cocaine taking, cocaine seeking, and locomotor activity in female rats.Perspectives on zebrafish models of hallucinogenic drugs and related psychotropic compounds.

P2860

Q21558551-2655E362-DED1-4BCC-9B38-257626424C9A Q22299243-37E4DE0B-231F-42F7-8C38-CDD3E76B27CC Q22305514-355AE457-69AB-4132-98AC-BFADD6BFA699 Q24602762-501CE136-F5A4-405B-830F-174453F198A6 Q24606265-96E6D12F-7D20-46AB-B8B7-45BA718ABFAD Q24620135-D569A362-A345-4947-A34A-6940955F7F8F Q24630561-0FF2113C-32FA-45C0-A948-D5CCFD4340B9 Q26770469-3FB1ABAC-5508-485F-91C4-A5BD8FF12AA3 Q26799231-6183199D-7AF8-47F8-AE61-6E825F32B877 Q27324786-E1B661F9-E6AD-4CFA-A24F-6BF4FCEAAAB4 Q27329826-4928B014-4260-4D8A-AB61-5FFD37AD6100 Q28540131-FBFD1572-1F8E-41FD-AEB1-405425CA7958 Q30357945-19ED953B-ABAD-45D8-8EE9-E70605434860 Q30404060-9BC8345F-7A66-47A2-9F7B-640331FF8F10 Q30544870-19FA25C6-B8A1-418C-A25A-6D29CFFF3BDF Q33390410-2D6304D0-4CC6-4B8F-ACC3-9B39AD3D3834 Q33455500-D7E5640D-B75E-41A5-A748-54BC6905A6D7 Q33620569-8293C614-76B8-414B-A916-C52D1145072F Q33641345-0DCB930B-0C8C-4307-904F-70C5DA4329B9 Q33870495-08345713-50E4-489E-A118-764794656804 Q34021568-0E39CB0F-DD17-494E-BB20-6A3574B2A652 Q34167689-F2B85F3A-CEE4-4573-9A4C-BC5D436BC5ED Q34309474-0D272EF7-E886-49BB-93E9-6754BB15595A Q34375625-93E2571B-7347-4694-A893-8E3D3E2183C7 Q34420092-E409A4C0-630E-4679-8EFD-1C230886898C Q34495787-D8C3CA14-0F3A-4243-B929-E195FBDA731E Q34502080-6F81344E-7C64-4B1C-8B81-A0018EE1C865 Q34523797-BDCF9683-26A9-4B7A-8184-612A9BF88468 Q34535259-FA0116C5-A5FA-4AC7-A2B8-BF87345736BA Q34551204-474610B5-EADC-4CB5-A3CE-1A85783A8DDA Q34643734-D55938A8-5A69-4C73-98FE-43702E327421 Q34674320-8EE23E41-FA2E-4567-AB8D-354B1BB2B3B7 Q35554326-E8448978-7D11-4B28-89B5-A3C009D67F4F Q35754068-C2BBBF13-E70B-4A29-9E46-678AF16E9EE3 Q35992610-5D6F92DB-0346-48F8-B24B-DC54B76C43E0 Q36253278-F5083A29-3CAE-4898-8662-0338EE52F489 Q36685572-8994495E-3674-4979-A129-F8B7A1CAD9FC Q36749707-3474E24E-C5FD-4271-BD9E-ADBF6B196BCC Q36768091-20A8CCFE-44B6-4C45-9E90-10AB6BEEAFBD Q37113859-55A14480-F5E0-4829-BBAA-2D16968CB19E

P2860

Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration.

http://www.wikidata.org/entity/Q34989613

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Increased oxytocin concentrati ...... thamphetamine) administration.

@ast

Increased oxytocin concentrati ...... thamphetamine) administration.

@en

Increased oxytocin concentrati ...... thamphetamine) administration.

@nl

type

label

Increased oxytocin concentrati ...... thamphetamine) administration.

@ast

Increased oxytocin concentrati ...... thamphetamine) administration.

@en

Increased oxytocin concentrati ...... thamphetamine) administration.

@nl

prefLabel

Increased oxytocin concentrati ...... thamphetamine) administration.

@ast

Increased oxytocin concentrati ...... thamphetamine) administration.

@en

Increased oxytocin concentrati ...... thamphetamine) administration.

@nl

P1433

Q34989613-27425E8E-B005-42A3-AA6E-58C2262C4008

P1476

Q34989613-5EFD072E-7103-4766-88CE-7158B7BC902F

P2093

Q34989613-082606C5-BA9E-4FC9-9F17-66C006C78317

Q34989613-38A4E337-A9FF-44AC-AD4D-929FB73C375F

Q34989613-8359D9EE-3A77-43BC-AFCD-1C551D5A0E9E

Q34989613-9C8C12F4-1ACF-4D95-9E02-A5168A58B4D7

Q34989613-B39B5623-14F2-40D8-BCDE-AB71AAAE46A4

Q34989613-B848EE26-4AC2-4CDF-AEB7-30E8FB6EB196

Q34989613-C77D691D-D8F3-4DC2-941F-5AEB29591824

Q34989613-F71139D3-9CF4-438C-B8A0-8820CAB42D87

P304

Q34989613-00813382-0399-4413-B929-A7399D897444

P31

Q34989613-41948B8D-C5DF-47BF-83D0-CB22D1996FED

P356

Q34989613-A5C19AFB-5A17-4310-ADAF-5AA7F47BAB03

P433

Q34989613-37EC5707-5DB8-4018-8A8B-931F7EA48D83

P478

Q34989613-C57A41C4-7055-42C2-A415-1DF1E81E1D81

P50

Q34989613-261CAE73-A1A2-4E86-9AD9-D617A92B1533

P577

Q34989613-B2E08F41-25C9-455C-B5F6-2CA813B5BDEE

P698

Q34989613-61B79AF9-12F8-43A0-9286-2B5933D66214

P921

Q34989613-C4FE5C5C-3070-4013-8A1E-F7784127FD42

P356

17470910802649470

P1433

Social Neuroscience

P1476

Increased oxytocin concentrati ...... ethamphetamine) administration

@en

P2093

A R T Donders

http://www.w3.org/2001/XMLSchema#string

D J Touw

http://www.w3.org/2001/XMLSchema#string

G J H Dumont

http://www.w3.org/2001/XMLSchema#string

J K Buitelaar

http://www.w3.org/2001/XMLSchema#string

J M A van Gerven

http://www.w3.org/2001/XMLSchema#string

R Hermsen

http://www.w3.org/2001/XMLSchema#string

R J Verkes

http://www.w3.org/2001/XMLSchema#string

R van der Steen

http://www.w3.org/2001/XMLSchema#string

P304

359-366

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/17470910802649470

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19562632

http://www.w3.org/2001/XMLSchema#string

P921